| Joshua H Whisler, PT | |
|
4605 Sawmill Rd, Upper Arlington, OH 43220-2246 | |
| (614) 827-8700 | |
| (614) 827-8701 |
| Full Name | Joshua H Whisler |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 24 Years |
| Location | 4605 Sawmill Rd, Upper Arlington, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104023696 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 009482 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic One, Inc. | 3072598283 | 253 |
News Archive
An international team, which included experts from China, Indonesia, Thailand, the US and Vietnam, say that domestic ducks possibly pose a major threat of spreading avian flu to animals and humans, as not only do they carry the virus with few visible signs, the virus is able to mutate in them, which means they could trigger a human pandemic.
Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.
Dongsheng Pharmaceutical International Co., Ltd. announced today that it has entered into an agreement with Shanghai Wan'Te Pharmaceutical Co., Ltd. to acquire the intellectual property, exclusive sales and manufacturing rights of micro-emulsion alprostadil injection from Wan'Te for total proceeds of RMB10 million, of which RMB5 million will be paid in cash and RMB5 million will be paid in shares of the Company's common stock.
GlaxoSmithKline Plc, one of the world's largest pharmaceutical companies, has agreed to pay $750 million to settle a U.S. government false-claims lawsuit over the sale of defective drugs. The lawsuit first filed in 2004 by Cheryl D. Eckard, a former global quality assurance manager for the London-based company came to a settlement finally. Eckard, 51, said, "This is not something I wanted to do, but because of patient safety it was necessary." Being the one to bring this to notice she would receive $96 million from the settlement money. She had warned the company earlier but was fired because of her efforts.
› Verified 3 days ago
| Provider Name | Orthopedic One, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1548289697 PECOS PAC ID: 3072598283 Enrollment ID: O20040622000841 |
News Archive
An international team, which included experts from China, Indonesia, Thailand, the US and Vietnam, say that domestic ducks possibly pose a major threat of spreading avian flu to animals and humans, as not only do they carry the virus with few visible signs, the virus is able to mutate in them, which means they could trigger a human pandemic.
Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.
Dongsheng Pharmaceutical International Co., Ltd. announced today that it has entered into an agreement with Shanghai Wan'Te Pharmaceutical Co., Ltd. to acquire the intellectual property, exclusive sales and manufacturing rights of micro-emulsion alprostadil injection from Wan'Te for total proceeds of RMB10 million, of which RMB5 million will be paid in cash and RMB5 million will be paid in shares of the Company's common stock.
GlaxoSmithKline Plc, one of the world's largest pharmaceutical companies, has agreed to pay $750 million to settle a U.S. government false-claims lawsuit over the sale of defective drugs. The lawsuit first filed in 2004 by Cheryl D. Eckard, a former global quality assurance manager for the London-based company came to a settlement finally. Eckard, 51, said, "This is not something I wanted to do, but because of patient safety it was necessary." Being the one to bring this to notice she would receive $96 million from the settlement money. She had warned the company earlier but was fired because of her efforts.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua H Whisler, PT Po Box 920120, Dallas, TX 75392-0120 Ph: () - | Joshua H Whisler, PT 4605 Sawmill Rd, Upper Arlington, OH 43220-2246 Ph: (614) 827-8700 |
News Archive
An international team, which included experts from China, Indonesia, Thailand, the US and Vietnam, say that domestic ducks possibly pose a major threat of spreading avian flu to animals and humans, as not only do they carry the virus with few visible signs, the virus is able to mutate in them, which means they could trigger a human pandemic.
Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.
Dongsheng Pharmaceutical International Co., Ltd. announced today that it has entered into an agreement with Shanghai Wan'Te Pharmaceutical Co., Ltd. to acquire the intellectual property, exclusive sales and manufacturing rights of micro-emulsion alprostadil injection from Wan'Te for total proceeds of RMB10 million, of which RMB5 million will be paid in cash and RMB5 million will be paid in shares of the Company's common stock.
GlaxoSmithKline Plc, one of the world's largest pharmaceutical companies, has agreed to pay $750 million to settle a U.S. government false-claims lawsuit over the sale of defective drugs. The lawsuit first filed in 2004 by Cheryl D. Eckard, a former global quality assurance manager for the London-based company came to a settlement finally. Eckard, 51, said, "This is not something I wanted to do, but because of patient safety it was necessary." Being the one to bring this to notice she would receive $96 million from the settlement money. She had warned the company earlier but was fired because of her efforts.
› Verified 3 days ago
Nicholas Matthew Bobinger, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4605 Sawmill Rd, Upper Arlington, OH 43220 Phone: 614-827-8700 Fax: 614-827-8701 | |
David Lee Neavin, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4605 Sawmill Rd, Upper Arlington, OH 43220 Phone: 614-827-8700 Fax: 614-827-8701 | |
Mrs. Nicole Marie Barber, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4605 Sawmill Rd, Upper Arlington, OH 43220 Phone: 614-827-8700 Fax: 614-827-8701 | |
Jon A Moore, Physical Therapist Medicare: Medicare Enrolled Practice Location: 4605 Sawmill Rd, Upper Arlington, OH 43220 Phone: 614-545-7900 Fax: 614-545-7901 | |
Ronald David Stiffler Jr., PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4605 Sawmill Rd, Upper Arlington, OH 43220 Phone: 614-827-8700 Fax: 614-827-8701 | |
Joseph Dominic Parisi, PT, DPT, ATC, CSCS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4605 Sawmill Rd, Upper Arlington, OH 43220 Phone: 614-827-8700 |